What is NDC 31722-557?

31722-557 is the product NDC for Abacavir, Abacavir sulfate 300 mg/1 tablet, listed with the FDA by Camber Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Camber Pharmaceuticals, Inc., NDC labeler code 31722. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Abacavir?

10 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Abacavir NDC 31722-557 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)31722-557Labeler and product segments. Claims need a package NDC.

Product NDC at billing width31722-0557Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
31722-557-60	31722055760	60 TABLET in 1 BOTTLE (31722-557-60)Marketed from Apr 1, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Abacavir
Generic name (nonproprietary): abacavir
Active ingredients: Abacavir sulfate — 300 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Camber Pharmaceuticals, Inc.NDC labeler code 31722
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091560
Marketing start: Apr 1, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 1A1 Inhibitors (Mechanism)Nucleoside Reverse Transcriptase Inhibitors (Mechanism)
Identifiers: Product ID 31722-557_55c3aae4-fa43-40fa-e063-6394a90ac974SPL ID 55c3aae4-fa43-40fa-e063-6394a90ac974SPL set ID 44fb1e25-ad03-4a7f-9f35-2e29f5025661RxCUI 242679UNII J220T4J9Q2
Pharmacologic class: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N431722055760 followed by a unit qualifier and the quantity

Package 31722-0557-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 4, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Abacavir tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus (HIV-1) infection. Abacavir, a nucleoside analogue human immunodeficiency virus (HIV-1) reverse transcriptase inhibitor, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 31722-557

What is NDC 31722-557?: 31722-557 is the product NDC for Abacavir, Abacavir sulfate 300 mg/1 tablet, listed with the FDA by Camber Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Abacavir.
What is the active ingredient?: Abacavir sulfate.
Who is the labeler?: Camber Pharmaceuticals, Inc., NDC labeler code 31722. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Abacavir?: 10 other product NDCs are listed under this name. See all Abacavir NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Abacavir NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Abacavir	Abacavir sulfate 300 mg/1	TabletOral	XLCare Pharmaceuticals Inc.	72865-167	72865-0167-60
Abacavir	Abacavir sulfate 300 mg/1	TabletOral	Coupler LLC	67046-1602	67046-1602-03
Abacavir	Abacavir sulfate 300 mg/1	TabletOral	AvPAK	50268-049	50268-0049-12
Abacavirabacavir sulfate	Abacavir sulfate 20 mg/mL	SolutionOral	Rising Pharma Holdings, Inc.	64980-405	64980-0405-24
Abacavirabacavir sulfate	Abacavir sulfate 20 mg/mL	SolutionOral	Aurobindo Pharma Limited	65862-089	65862-0089-24
Abacavir	Abacavir sulfate 300 mg/1	Tablet, Film coatedOral	Cipla USA Inc.	69097-514	69097-0514-03
Abacavir	Abacavir sulfate 20 mg/mL	SolutionOral	Camber Pharmaceuticals, Inc.	31722-562	31722-0562-24
Abacavir	Abacavir sulfate 300 mg/1	Tablet, Film coatedOral	American Health Packaging	68084-021	68084-0021-21
Abacavir	Abacavir sulfate 300 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-6874	00904-6874-0400904-6874-06
Abacavir	Abacavir sulfate 300 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-073	65862-0073-60

Other NDCs under ANDA 091560

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091560
Product	Strength	Form · route	Labeler	Product NDC
Abacavir	Abacavir sulfate 300 mg/1	TabletOral	AvPAK	50268-049
Abacavir	Abacavir sulfate 300 mg/1	TabletOral	Coupler LLC	67046-1602
Abacavir	Abacavir sulfate 300 mg/1	TabletOral	XLCare Pharmaceuticals Inc.	72865-167